首页
订购/客服:400-666-5481

CCT196969

    
10mM in DMSO

CCT196969

源叶(MedMol)
S54124 一键复制产品信息
1163719-56-9
C27H24FN7O3
513.52
Urea,N-​[4-​[(3,​4-​dihydro-​3-​oxopyrido[2,​3-​b]​pyrazin-​8-​yl)​oxy]​-​2-​fluorophenyl]​-​N'-​[3-​(1,​1-​dimethylethyl)​-​1-​phenyl-​1H-​pyrazol-​5-​yl]​-
货号 规格 价格 上海 北京 珠海 重庆 武汉 购买数量
S54124-1ml促销
10mM in DMSO

¥720.00 ¥648.00

8 - - - -
产品介绍 参考文献 质检证书(COA) 摩尔浓度计算器 相关产品
产品描述: C-Raf/Raf-1 选择性抑制剂;C-Raf/Raf-1 Selective Inhibitors;;InformationCCT196969 is a novel orally available, pan-RAFinhibitor with anti-SRCactivity. It also inhibits SRC, LCK, and the p38 MAPKs.TargetsCRAF (Cell-free assay); LCK (Cell-free assay); Src (Cell-free assay); V600E-BRAF (Cell-free assay); BRAF (Cell-free assay) ;0.01 μM; 0.02 μM; 0.03 μM; 0.04 μM; 0.1 μMIn vitroCCT196969 is active against melanoma and colorectal cancer cell lines that are mutant for BRAF, but not cancer cells that are wild-type for BRAF and NRAS. CCT196969 induces caspase 3 and PARP cleavage, thus induces apoptosis. CCT196969 does not drive paradoxical pathway activation and inhibit MEK/ERK in BRAF and NRAS mutant melanoma.In vivoCCT196969 is extremely well tolerated at the doses assessed and does not produce any significant adverse effects in vivo. Oral dosing at 10 mg/kg/day of CCT196969 results in plasma concentrations ∼1 μM at 24 hr. It is orally bioavailable at ∼55%.Cell Research(from reference)Cell lines:cell line derived from a vemurafenib-resistant melanoma Concentrations:1 μM Incubation Time:4 h 
保存条件: -80℃(运输条件:冰袋低温运输)
配置溶液浓度参考:
1mg 5mg 10mg
1 mM 1.947 ml 9.737 ml 19.473 ml
5 mM 0.389 ml 1.947 ml 3.895 ml
10 mM 0.195 ml 0.974 ml 1.947 ml
50 mM 0.039 ml 0.195 ml 0.389 ml
注意: 部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。

参考文献

质检证书(COA)

如何获取质检证书(COA)?
请输入货号和一个与之匹配的批号。
例如:
批号:JS298415 货号:S20001-25g
在货品标签上如何找到货号和批号?

摩尔浓度计算器

质量 (mg) = 浓度 (mM) x 体积 (mL) x 分子摩尔量 (g/mol)

=
×
×